Deep Track Capital, LP
Filing Date
Global Rank
#612
/ 8,700
▲ 129
Top Industry
Biotechnology
81.6%
Period ended 2 months ago
Filed Aug 14, 2026 · 29d
19 quarters · since Dec 2021
Portfolio Concentration
66 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
7.7%
−15.2 pts
Top 5
24.4%
−18.2 pts
Top 10
41.2%
−17.0 pts
HHI
293
Diversified−434
Portfolio Trend
19 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $6,650,249,903 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
22 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| GMAB | Genmab A/S | +4,986,750 | 8,650,000 | $237,615,500 | |
| ATAI | AtaiBeckley Inc. | +2,417,442 | 14,417,442 | $75,979,919 | |
| VRDN | Viridian Therapeutics, Inc.\DE | +2,198,796 | 3,592,740 | $65,998,633 | |
| BMRN | Biomarin Pharmaceutical Inc | +2,157,481 | 3,307,481 | $189,254,062 | |
| CLDX | Celldex Therapeutics, Inc. | +1,655,172 | 2,939,151 | $109,365,808 | |
| MANE | Veradermics, Inc | +1,500,000 | 2,000,000 | $245,880,000 | |
| TNGX | Tango Therapeutics, Inc. | +1,450,000 | 4,200,000 | $131,292,000 | |
| NRIX | Nurix Therapeutics, Inc. | +1,391,211 | 7,736,455 | $187,686,398 | |
| COGT | Cogent Biosciences, Inc. | +1,000,000 | 2,000,000 | $77,400,000 | |
| PSNL | Personalis, Inc. | +1,000,000 | 4,000,000 | $53,600,000 | |
| MLTX | MoonLake Immunotherapeutics | +590,162 | 6,999,025 | $136,271,016 | |
| GPCR | Structure Therapeutics Inc. | +460,224 | 4,740,072 | $254,399,664 | |
| ALKS | Alkermes plc. | +409,677 | 4,000,000 | $209,600,000 | |
| — | +406,998 | 1,783,322 | $0 | ||
| MAZE | Maze Therapeutics, Inc. | +255,007 | 3,732,569 | $111,379,858 | |
| IONS | Ionis Pharmaceuticals Inc | +250,000 | 2,200,000 | $174,438,000 | |
| BEAM | Beam Therapeutics Inc. | +179,235 | 1,000,000 | $34,320,000 | |
| GRAL | GRAIL, Inc. | +112,147 | 1,834,944 | $125,271,626 | |
| TARS | Tarsus Pharmaceuticals, Inc. | +66,768 | 3,666,768 | $230,786,377 | |
| GH | Guardant Health, Inc. | +55,071 | 3,393,312 | $509,098,599 | |
| BCAX | Bicara Therapeutics Inc. | +37,500 | 4,100,000 | $121,729,000 | |
| CRVS | Corvus Pharmaceuticals, Inc. | +400 | 2,491,939 | $37,229,568 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
15 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | −2,185,820 | 9,341,151 | $359,914,548 | |
| IMCR | Immunocore Holdings plc | −1,620,666 | 311,218 | $9,881,171 | |
| MBX | MBX Biosciences, Inc. | −1,025,000 | 1,732,569 | $95,637,808 | |
| CYTK | Cytokinetics Inc | −674,320 | 700,000 | $59,633,000 | |
| KURA | Kura Oncology, Inc. | −664,977 | 1,978,565 | $21,704,858 | |
| ENTA | Enanta Pharmaceuticals Inc | −512,700 | 1,444,167 | $21,055,954 | |
| DYN | Dyne Therapeutics, Inc. | −500,000 | 1,500,000 | $33,315,000 | |
| XFOR | X4 Pharmaceuticals, Inc | −460,778 | 5,878,757 | $27,453,795 | |
| ALMS | Alumis Inc. | −424,037 | 6,348,558 | $178,648,422 | |
| IVA | Inventiva S.A. | −422,453 | 800,000 | $3,024,000 | |
| AXSM | Axsome Therapeutics, Inc. | −400,000 | 700,000 | $171,339,000 | |
| DFTX | Definium Therapeutics, Inc. | −250,000 | 2,750,000 | $129,360,000 | |
| ORKA | Oruka Therapeutics, Inc. | −108,203 | 1,926,000 | $183,297,420 | |
| VERA | Vera Therapeutics, Inc. | −106,067 | 4,000,000 | $171,640,000 | |
| IPSC | Century Therapeutics, Inc. | −25,100 | 9,462,645 | $23,183,480 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
18 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals, Inc. | 825,000 | $248,349,750 | |
| COAG | Hemab Therapeutics Holdings, Inc. | 3,602,093 | $132,304,875 | |
| GHRS | GH Research PLC | 3,333,334 | $89,600,017 | |
| UTHR | UNITED THERAPEUTICS Corp | 123,616 | $66,978,857 | |
| AVTX | Avalo Therapeutics, Inc. | 3,610,000 | $66,712,800 | |
| ALT | Altimmune, Inc. | 19,250,000 | $58,520,000 | |
| WGS | GeneDx Holdings Corp. | 700,000 | $48,055,000 | |
| HROW | Harrow, Inc. | 969,000 | $41,153,430 | |
| IMMX | Immix Biopharma, Inc. | 2,775,000 | $28,610,250 | |
| STTK | Shattuck Labs, Inc. | 3,706,734 | $25,724,733 | |
| MNKD | Mannkind Corp | 6,000,000 | $25,560,000 | |
| GENB | Generate Biomedicines, Inc. | 1,333,815 | $22,501,459 | |
| NKTR | Nektar Therapeutics | 300,000 | $20,943,000 | |
| OLMA | Olema Pharmaceuticals, Inc. | 1,500,000 | $18,765,000 | |
| KLRA | Kailera Therapeutics, Inc. | 700,000 | $15,421,000 | |
| KARD | Kardigan, Inc. | 600,000 | $14,310,000 | |
| ELVN | Enliven Therapeutics, Inc. | 225,000 | $11,418,750 | |
| XNCR | Xencor Inc | 593,551 | $9,556,171 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
15 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| BWX | State Street SPDR Bloomberg International Treasury Bond ETF | 10,000,000 | $1,277,300,000 | |
| BBIO | BridgeBio Pharma, Inc. | 841,445 | $62,485,705 | |
| GERN | Geron Corp | 31,720,278 | $47,263,214 | |
| ANIP | Ani Pharmaceuticals Inc | 600,000 | $46,140,000 | |
| ENGN | enGene Therapeutics Inc. | 4,377,572 | $29,811,265 | |
| APGE | Apogee Therapeutics, Inc. | 285,000 | $23,988,450 | |
| JANX | Janux Therapeutics, Inc. | 1,187,290 | $16,503,331 | |
| CBIO | Crescent Biopharma, Inc. | 453,686 | $8,334,211 | |
| LRMR | Larimar Therapeutics, Inc. | 1,500,000 | $6,750,000 | |
| HELP | Cybin Inc. | 1,313,137 | $6,303,057 | |
| BLLN | BillionToOne, Inc. | 50,000 | $3,947,000 | |
| — | 4,532,374 | $0 | ||
| — | 1,078,710 | $0 | ||
| — | 1,073,877 | $0 | ||
| CNTA | Centessa Pharmaceuticals plc | 3,158,041 | $0 | |
| No positions match the current search. | ||||
66 tracked positions ·
$6,650,249,903 total
· filing declares
67 positions · $6,870,469,447
· as of Jun 30, 2026
Showing 1–50
of 66 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| GH |
Guardant Health, Inc.
Healthcare
|
Added | 3,393,312 | $509,098,599 | 7.66% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Reduced | 9,341,151 | $359,914,548 | 5.41% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 4,740,072 | $254,399,664 | 3.83% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Held | 4,300,000 | $249,959,000 | 3.76% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
NEW | 825,000 | $248,349,750 | 3.73% | |
| MANE |
Veradermics, Inc
Healthcare
|
Added | 2,000,000 | $245,880,000 | 3.70% | |
| GMAB |
Genmab A/S
CALL
+ SHARES
Healthcare
|
Added | 8,650,000 | $237,615,500 | 3.57% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Added | 3,666,768 | $230,786,377 | 3.47% | |
| ALKS |
Alkermes plc.
Healthcare
|
Added | 4,000,000 | $209,600,000 | 3.15% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
Held | 19,686,282 | $193,319,289 | 2.91% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 3,307,481 | $189,254,062 | 2.85% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Added | 7,736,455 | $187,686,398 | 2.82% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
Reduced | 1,926,000 | $183,297,420 | 2.76% | |
| ALMS |
Alumis Inc.
Healthcare
|
Reduced | 6,348,558 | $178,648,422 | 2.69% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 2,200,000 | $174,438,000 | 2.62% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
Held | 12,161,496 | $172,085,168 | 2.59% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 4,000,000 | $171,640,000 | 2.58% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Reduced | 700,000 | $171,339,000 | 2.58% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
Added | 6,999,025 | $136,271,016 | 2.05% | |
| COAG |
Hemab Therapeutics Holdings, Inc.
Healthcare
|
NEW | 3,602,093 | $132,304,875 | 1.99% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Added | 4,200,000 | $131,292,000 | 1.97% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
Reduced | 2,750,000 | $129,360,000 | 1.95% | |
| GRAL |
GRAIL, Inc.
Healthcare
|
Added | 1,834,944 | $125,271,626 | 1.88% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Added | 4,100,000 | $121,729,000 | 1.83% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
Added | 3,732,569 | $111,379,858 | 1.67% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Added | 2,939,151 | $109,365,808 | 1.64% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
Held | 3,352,804 | $108,815,253 | 1.64% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Reduced | 1,732,569 | $95,637,808 | 1.44% | |
| GHRS |
GH Research PLC
Healthcare
|
NEW | 3,333,334 | $89,600,017 | 1.35% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Added | 2,000,000 | $77,400,000 | 1.16% | |
| ATAI |
AtaiBeckley Inc.
Healthcare
|
Added | 14,417,442 | $75,979,919 | 1.14% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
NEW | 123,616 | $66,978,857 | 1.01% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
NEW | 3,610,000 | $66,712,800 | 1.00% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Added | 3,592,740 | $65,998,633 | 0.99% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 700,000 | $59,633,000 | 0.90% | |
| ALT |
Altimmune, Inc.
Healthcare
|
NEW | 19,250,000 | $58,520,000 | 0.88% | |
| PSNL |
Personalis, Inc.
Healthcare
|
Added | 4,000,000 | $53,600,000 | 0.81% | |
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
Held | 9,345,000 | $49,435,050 | 0.74% | |
| CRMD |
CorMedix Inc.
Healthcare
|
Held | 6,274,076 | $49,251,496 | 0.74% | |
| WGS |
GeneDx Holdings Corp.
Healthcare
|
NEW | 700,000 | $48,055,000 | 0.72% | |
| HROW |
Harrow, Inc.
Healthcare
|
NEW | 969,000 | $41,153,430 | 0.62% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
Added | 2,491,939 | $37,229,568 | 0.56% | |
| SLDB |
Solid Biosciences Inc.
Healthcare
|
Held | 3,565,062 | $35,614,969 | 0.54% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
Added | 1,000,000 | $34,320,000 | 0.52% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Reduced | 1,500,000 | $33,315,000 | 0.50% | |
| IMMX |
Immix Biopharma, Inc.
Healthcare
|
NEW | 2,775,000 | $28,610,250 | 0.43% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
Reduced | 5,878,757 | $27,453,795 | 0.41% | |
| STTK |
Shattuck Labs, Inc.
Healthcare
|
NEW | 3,706,734 | $25,724,733 | 0.39% | |
| MNKD |
Mannkind Corp
Healthcare
|
NEW | 6,000,000 | $25,560,000 | 0.38% | |
| IPSC |
Century Therapeutics, Inc.
Healthcare
|
Reduced | 9,462,645 | $23,183,480 | 0.35% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.